These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8532725)

  • 41. Liver cell proliferation and tumor promotion by phenobarbital: relevance for humans?
    Braeuning A
    Arch Toxicol; 2014 Oct; 88(10):1771-2. PubMed ID: 25141972
    [No Abstract]   [Full Text] [Related]  

  • 42. Mouse liver tumors: the problem.
    McConnell EE
    Prog Clin Biol Res; 1990; 331():1-3. PubMed ID: 2179955
    [No Abstract]   [Full Text] [Related]  

  • 43. Commentary on "Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary".
    Long GG
    Toxicol Pathol; 2010 Apr; 38(3):502-5. PubMed ID: 20124495
    [No Abstract]   [Full Text] [Related]  

  • 44. Genetic control of hepatocarcinogenesis in C3H mice.
    Drinkwater NR
    Drug Metab Rev; 1994; 26(1-2):201-8. PubMed ID: 8082565
    [No Abstract]   [Full Text] [Related]  

  • 45. Organochlorine insecticides and mouse liver tumors: an analysis of responses and mechanisms.
    Stevenson DE
    Prog Clin Biol Res; 1990; 331():367-83. PubMed ID: 2179962
    [No Abstract]   [Full Text] [Related]  

  • 46. Correspondence re: F. F. Becker. Morphological classification of mouse liver tumors based on biological characteristics. Cancer Res., 42: 3918-3923, 1982.
    Goldforb S; Pugh TD; Koen H
    Cancer Res; 1984 Feb; 44(2):869-70. PubMed ID: 6692387
    [No Abstract]   [Full Text] [Related]  

  • 47. Role of altered hepatic foci in the stages of carcinogenesis.
    Pitot HC; Dragan Y; Xu YH; Pyron M; Laufer C; Rizvi T
    Prog Clin Biol Res; 1990; 340D():81-95. PubMed ID: 2196586
    [No Abstract]   [Full Text] [Related]  

  • 48. Interspecies comparison of liver carcinogenesis: implications for cancer risk assessment.
    Grisham JW
    Carcinogenesis; 1997 Jan; 18(1):59-81. PubMed ID: 9054591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of a model to simulate the characteristics of rat liver tumor promotion by phenobarbital.
    Stevens FJ; Peraino C
    Carcinog Compr Surv; 1982; 7():105-9. PubMed ID: 7066914
    [No Abstract]   [Full Text] [Related]  

  • 50. The Mode of Action for Phenobarbital-Induced Rodent Liver Tumor Formation Is not Relevant for Humans: Recent Studies With Humanized Mice.
    Yamada T; Cohen SM; Lake BG
    Toxicol Sci; 2015 Oct; 147(2):298-9. PubMed ID: 26408565
    [No Abstract]   [Full Text] [Related]  

  • 51. [Hepatic tumor promotion--role of environmental factors. A symposium. Paris, April 27-28, 1989. Proceedings].
    Bull Cancer; 1990; 77(5):453-519. PubMed ID: 2400815
    [No Abstract]   [Full Text] [Related]  

  • 52. Methylene chloride.
    Huff J; Bucher J; Barrett JC
    Science; 1996 May; 272(5265):1083-4. PubMed ID: 8638144
    [No Abstract]   [Full Text] [Related]  

  • 53. Carcinogenicity and cocarcinogenicity test of phenobarbital sodium in adult BALB/c mice.
    Cavaliere A; Bufalari A; Vitali R
    Tumori; 1986 Apr; 72(2):125-8. PubMed ID: 3705183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The International Life Sciences Institute's role in the evaluation of alternative methodologies for the assessment of carcinogenic risk.
    Robinson D
    Toxicol Pathol; 1998; 26(4):474-5. PubMed ID: 9715505
    [No Abstract]   [Full Text] [Related]  

  • 55. Some observations on mouse liver tumors.
    Stevenson DE
    Prog Clin Biol Res; 1990; 331():43-51. PubMed ID: 2179963
    [No Abstract]   [Full Text] [Related]  

  • 56. Tamoxifen experimental carcinogenicity studies: implications for human effects.
    Williams GM
    Proc Soc Exp Biol Med; 1995 Feb; 208(2):141-3. PubMed ID: 7831345
    [No Abstract]   [Full Text] [Related]  

  • 57. Can so-called nongenotoxic hepatocarcinogens induce mouse liver nodules that are not neoplasms?
    Ward JM
    Toxicol Pathol; 1996; 24(4):505. PubMed ID: 8864194
    [No Abstract]   [Full Text] [Related]  

  • 58. Pharmacokinetics and cancer risk assessments.
    Kedderis GL; McClellan RO; Conolly RB
    Regul Toxicol Pharmacol; 1994 Jun; 19(3):338-40; discussion 341. PubMed ID: 8090956
    [No Abstract]   [Full Text] [Related]  

  • 59. Further mechanisms of non-genotoxic carcinogenesis.
    Paolini M; Biagi GL; Cantelli-Forti G; Bauer C
    Trends Pharmacol Sci; 1994 Sep; 15(9):322-3. PubMed ID: 7992385
    [No Abstract]   [Full Text] [Related]  

  • 60. Mouse liver carcinogenesis: mechanisms and species comparisons. Proceedings of a symposium. Austin, Texas, November 30-December 3, 1988.
    Prog Clin Biol Res; 1990; 331():1-427. PubMed ID: 2315338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.